![George Ji](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Patrick Lu | M | 68 |
Sirnaomics, Inc.
![]() Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD.
Guangzhou Natai Biomedical Technology Co., Ltd.
![]() Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | 17 years |
David Evans | M | 61 |
Sirnaomics, Inc.
![]() Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | 17 years |
Danny Tang | M | - |
Guangzhou Natai Biomedical Technology Co., Ltd.
![]() Guangzhou Natai Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Part of Sirnaomics, Inc., Guangzhou Natai Biomedical Technology Co., Ltd. is a company that manufactures biomedical products. The company is based in Guangzhou, China. Guangzhou Natai Biomedical Technology Co. was acquired by Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. The Chinese company was founded in 2012 by Yang Lu, Jian Jun Ji, Sheng Gao Tang. Sheng Gao Tang has been the CEO since 2012. | 12 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Marc Lemaitre | M | - |
Sirnaomics, Inc.
![]() Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Sirnaomics, Inc. develops novel targeted therapeutics for critical human diseases. It discovers and develops RNAi therapeutics. The firm pursues its proprietary technologies using pluripotent siRNA cocktail design and nanoparticle-enhanced therapeutic delivery to treat critical human diseases. The company was founded by Patrick Y. Lu, George Ji and David M. Evans in 2007 and is headquartered in Gaithersburg, MD. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 3 | 75.00% |
China | 2 | 50.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- George Ji
- Personal Network